http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
OvaScience Announces Executive Management Changes and Appointments to Further Drive Company’s Growth
-
OvaScience Announces Executive Management Changes and Appointments to Further Drive Company’s Growth
-
OvaScience to Present at Upcoming Investor Conferences in September
-
OvaScience Reports Second Quarter 2016 Financial Results
-
OvaScience to Host Second Quarter 2016 Financial Results Conference Call
-
Harald Stock, Ph.D. Commences Role as President and Chief Executive Officer of OvaScience
-
OvaScience Reports First Quarter 2016 Financial Results
-
OvaScience to Host First Quarter 2016 Financial Results Conference Call
-
OvaScience Announces Senior Management Changes and Appointments
-
OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
OvaScience to Present at Cowen and Company Health Care Conference
-
OvaScience Reports Fourth Quarter and Year-End 2015 Financial Results
-
OvaScience Appoints Paul W.D. Chapman to Chief Operating Officer
-
OvaScience to Host Fourth Quarter and Fiscal Year 2015 Financial Results Conference Call
-
OvaScience to Present at Leerink Global Healthcare Conference
-
SHAREHOLDER NOTICE: Goldberg Law PC Announces an Ongoing Investigation of Claims against OvaScience, Inc. and Advises Investors with Losses to Contact the Firm
-
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against OvaScience, Inc. and Advises Investors With Losses to Contact the Firm
-
OvaScience Announces 2016 Corporate Goals for Its Core Fertility Treatments
-
OvaScience (OVAS) Says AUGMENT Fertility Treatment is Available in Japan
-
OvaScience’s AUGMENT Fertility Treatment Available in Japan
-
OvaScience to Present at the Oppenheimer Healthcare Conference
-
OvaScience (OVAS) Reaches OvaPrime and OvaTure Goals for 2015; Offers Update
-
OvaScience Provides Business Update and Outlines 2015 Corporate Progress
-
OvaScience Reports Third Quarter 2015 Financial Results
-
OvaScience Provides Update on Corporate Goal for AUGMENT Treatment
-
OvaScience to Present at the Rodman & Renshaw/H.C. Wainwright Annual Global Investment Conference
-
Publication of OvaScience’s AUGMENT Fertility Treatment Shows Statistically Significant Improvements in Embryo Selection and Transfer Compared to Standard IVF
-
Improved Pregnancy Rates and Healthy Births with OvaScience’s AUGMENT Fertility Treatment to be Published in Peer-Reviewed Journal
-
OvaScience Reports Second Quarter 2015 Financial Results
-
OvaScience Expands AUGMENT℠ Fertility Treatment Offering through IVI Group, the Largest IVF Clinic Network in the World
-
OvaScience to Present at the Wedbush PacGrow Healthcare Conference
-
OvaScience to Present at the JMP Securities Life Sciences Conference
-
OvaScience’s AUGMENT Treatment Shows Improved Pregnancy Rates and Live Births in Women with Poor Prognoses as Reported by Physicians During Annual International Fertility Meeting
-
OvaScience Expands Senior Team with Two New Key Hires
-
OvaScience Welcomes John Howe, M.D., Former President and CEO of Project HOPE, to Board of Directors
-
OvaScience to Present at the Jefferies 2015 Global Healthcare Conference
-
OvaScience Announces Ravi Mehrotra, Ph.D., Joins as Chief Corporate Development Officer
-
OvaScience’s AUGMENT Fertility Treatment Continues to Demonstrate Improved Pregnancy Rates in Women with Very Poor Prognoses
-
OvaScience Reports First Quarter 2015 Financial Results
-
First Baby Born with OvaScience’s AUGMENT Fertility Treatment
-
OvaScience Welcomes John Sexton, President of New York University, to Board of Directors
-
Additional Clinical Reports of OvaScience AUGMENT Fertility Treatment Show Improved Pregnancy Rates in Women with Multiple Prior Failed IVF Cycles
-
OvaScience AUGMENT Fertility Treatment Shows Improved Pregnancy Rates in Women with Prior Failed IVF Cycles
-
OvaScience to Host Conference Call and Webcast Presentation with IVF Specialists to Review Early AUGMENT Fertility Treatment Patient Experience
-
AUGMENT Fertility Treatment to be Highlighted at Society for Reproductive Investigation (SRI) Annual Meeting
-
OvaScience CEO Michelle Dipp Elected as Young Global Leader by World Economic Forum
-
OvaScience Reports Fourth Quarter and Year End 2014 Financial Results
-
OvaScience Reports Second Quarter 2014 Financial Results

